The development of a Tc-radiotracer for imaging of β-amyloid (Aβ) plaques with single photon emission computed tomography (SPECT) is strongly anticipated to provide a low cost and broadly accessible diagnostic tool for Alzheimer's disease (AD). Within this framework, 2-(4'-aminophenyl)benzothiazole, known to display affinity and specificity for Aβ plaques, has been joined to the tricarbonyl -[M(CO)] (M = Re(I), Tc(I)) core through the cyclopentadienyl moiety to yield stable, neutral, and lipophilic complexes ( and , respectively). The complex was completely characterized with spectroscopic methods and was shown to selectively stain Aβ plaques on sections of human AD brain tissue. The complex displayed satisfactory initial brain uptake (0.53% ID/g at 2 min) and stability in healthy mice, while in transgenic 5xFAD mice, models for AD, a notable retention in the brain was noted (1.94% ID/g at 90 min). The results are encouraging and contribute to the effort of developing a SPECT amyloid imaging agent.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641965PMC
http://dx.doi.org/10.1021/acsmedchemlett.7b00294DOI Listing

Publication Analysis

Top Keywords

aβ plaques
12
imaging β-amyloid
8
id/g min
8
2-4'-aminophenylbenzothiazole labeled
4
labeled tc-cyclopentadienyl
4
tc-cyclopentadienyl imaging
4
plaques
4
β-amyloid plaques
4
plaques development
4
development tc-radiotracer
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!